Menu
GeneBe

EXOSC10

exosome component 10, the group of Exosome complex

Basic information

Region (hg38): 1:11066617-11099869

Previous symbols: [ "PMSCL2" ]

Links

ENSG00000171824NCBI:5394OMIM:605960HGNC:9138Uniprot:Q01780AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EXOSC10 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
43
clinvar
2
clinvar
45
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 43 2 1

Variants in EXOSC10

This is a list of pathogenic ClinVar variants found in the EXOSC10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-11066734-T-C not specified Uncertain significance (Apr 25, 2022)2383402
1-11068021-C-T not specified Uncertain significance (May 24, 2024)3276822
1-11068039-T-C not specified Uncertain significance (Nov 27, 2023)3091188
1-11068042-T-G not specified Uncertain significance (Aug 28, 2023)2621773
1-11068080-C-T not specified Uncertain significance (Jan 04, 2022)2269349
1-11068691-T-C not specified Uncertain significance (Jan 23, 2023)2477927
1-11069598-G-C not specified Uncertain significance (Apr 22, 2024)3276824
1-11070913-C-T Likely benign (Apr 01, 2023)2638217
1-11070917-C-T not specified Uncertain significance (Jan 18, 2023)2458050
1-11070943-T-C not specified Uncertain significance (Oct 06, 2023)3091186
1-11072089-G-C not specified Uncertain significance (Apr 19, 2023)2520102
1-11073927-C-T Likely benign (Feb 01, 2024)3024718
1-11073948-T-C Likely benign (Jan 01, 2023)2638218
1-11073972-G-C not specified Uncertain significance (Oct 27, 2022)2321381
1-11073981-G-C not specified Uncertain significance (Mar 21, 2024)3276827
1-11074272-C-T not specified Uncertain significance (Dec 15, 2023)3091185
1-11076853-T-A not specified Uncertain significance (May 30, 2023)2513257
1-11077376-A-G not specified Uncertain significance (Nov 07, 2022)2322739
1-11077413-C-G not specified Uncertain significance (Jul 12, 2023)2590909
1-11077440-A-T not specified Uncertain significance (Jan 06, 2023)2474145
1-11077633-C-T not specified Uncertain significance (Oct 13, 2023)3091183
1-11079734-C-T not specified Uncertain significance (Jun 07, 2024)3276825
1-11079779-G-T not specified Uncertain significance (Feb 28, 2024)3091182
1-11080866-T-C not specified Uncertain significance (Dec 06, 2021)2401983
1-11081096-C-T not specified Uncertain significance (Aug 16, 2021)2385119

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EXOSC10protein_codingprotein_codingENST00000376936 2533264
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.97e-140.9991256680801257480.000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8704535080.8910.00002835840
Missense in Polyphen129172.880.746172029
Synonymous-0.04081941931.000.00001141644
Loss of Function3.193258.30.5490.00000321619

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007820.000782
Ashkenazi Jewish0.00009920.0000992
East Asian0.0004910.000489
Finnish0.00009250.0000924
European (Non-Finnish)0.0002830.000281
Middle Eastern0.0004910.000489
South Asian0.0004290.000425
Other0.0006540.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. EXOSC10 has 3'-5' exonuclease activity (By similarity). EXOSC10 is required for nucleolar localization of C1D and probably mediates the association of MTREX, C1D and MPP6 wth the RNA exosome involved in the maturation of 5.8S rRNA. {ECO:0000250, ECO:0000269|PubMed:14527413, ECO:0000269|PubMed:16455498, ECO:0000269|PubMed:17412707, ECO:0000269|PubMed:17545563, ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:19056938, ECO:0000269|PubMed:20368444, ECO:0000269|PubMed:20699273}.;
Pathway
RNA degradation - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.306

Intolerance Scores

loftool
0.0801
rvis_EVS
-1.24
rvis_percentile_EVS
5.49

Haploinsufficiency Scores

pHI
0.377
hipred
Y
hipred_score
0.648
ghis
0.626

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.963

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Exosc10
Phenotype
normal phenotype;

Gene ontology

Biological process
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;maturation of 5.8S rRNA;nuclear-transcribed mRNA catabolic process;rRNA processing;dosage compensation by inactivation of X chromosome;negative regulation of telomere maintenance via telomerase;nuclear mRNA surveillance;CUT catabolic process;nuclear polyadenylation-dependent rRNA catabolic process;histone mRNA catabolic process;nuclear retention of unspliced pre-mRNA at the site of transcription;RNA phosphodiester bond hydrolysis, exonucleolytic;regulation of telomerase RNA localization to Cajal body
Cellular component
nuclear exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;membrane;transcriptionally active chromatin
Molecular function
nucleotide binding;3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding;telomerase RNA binding